JEFFREY D KLAUSNER
Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease LOS ANGELES, CA NPI 1508973249
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease CA Visby Medical, Inc. All categories
General Payments — all program years on this page
$177,107.42
- Category: General Payments
- Program years: PY2018–2024
- Record count: 44
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $7,009.91 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $6,287.50 | 4 |
| Honoraria | $536.00 | 1 |
| Travel and Lodging | $94.14 | 1 |
| Food and Beverage | $92.27 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Visby Medical, Inc. | $3,187.50 | 2 |
| Abbott Laboratories | $2,250.00 | 1 |
| BioFire Diagnostics, LLC | $850.00 | 1 |
| La Jolla Pharmaceutical Company | $701.63 | 3 |
| Gilead Sciences, Inc. | $20.78 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1098248618 | Visby Medical, Inc. | $850.00 | 08/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1098248620 | Visby Medical, Inc. | $2,337.50 | 09/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1125415031 | Abbott Laboratories | $2,250.00 | 01/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1133842954 | Gilead Sciences, Inc. | $20.78 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147101687 | BioFire Diagnostics, LLC | $850.00 | 11/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1154249266 | La Jolla Pharmaceutical Company | $536.00 | 10/10/2024 | Honoraria | Undisputed | 01/23/2026 | View at CMS |
| 1154249268 | La Jolla Pharmaceutical Company | $94.14 | 10/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 1154249270 | La Jolla Pharmaceutical Company | $71.49 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.